does stopping tirzepatide cause weight gain Tirzepatide: Risk & Continuity Plans Tirzepatide: A Breakthrough Approach to

and WEGOVY Biotherapeutic GLP-1 receptor agonist Semaglutide LAI is a once-weekly subcutaneous GLP-1 receptor agonist (94% homologous to human GLP-1) indicated for glycemic control in type 2 diabetes

The study is a major win for GLP-1s and mental health

& Retnakaran, R

Usui R, Yabe D, Kuwata H, Fujiwara S, Watanabe K, Hyo T, Yasuhara A, Iwasaki M, Kitatani N, Kuwabara K, Yokota K, Kurose T, Seino Y

Vitamin D Vitamin D is well known for supporting bones and immunity, but it also plays an important role in brain health and recovery from injury

These studies raise the question that GLP-1 receptor agonists need to be tested further as potential treatments for those with alcohol addiction as well as other addictive disorders